Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipranavir/ritonavir versus darunavir/ritonavir in treatment-experienced HIV-1 patients with protease inhibitor resistance
2005-001866-15Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Aptivus/ritonavir with Prezista/ritonavir (2 arms). Primary endpoint: Time to virologic failure. Started Jun 2007; status: completed.
02
Drugs
tipranavirdarunavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-001866-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001866-15.